A Genética Aplicada é uma companhia privada com um portfolio de propriedade intelectual focado em Medicina Veterinária Regenerativa.
Investidores interessados em nossa tecnologia, entrem em contato no email:
enricojcs@geneticaplicada.com.br
Texto extraído da Revista Biotechnology Business:
The cell therapy market will near $30 billion by 2010.
The corporations pioneering cell therapy are heading for significant change. One of the emerging therapies fueling growth is stem cell therapy. Many investors and large companies that have preferred to avoid the possible controversies of embryonic stem cells are finding alternatives in adult stem cells. The potential use of adult stem cells for therapies may offer substantial opportunities for cell therapy companies looking to capitalize on a market that is currently estimated to exceed $500 million in the U.S. and Europe
enricojcs@geneticaplicada.com.br
Texto extraído da Revista Biotechnology Business:
The cell therapy market will near $30 billion by 2010.
The corporations pioneering cell therapy are heading for significant change. One of the emerging therapies fueling growth is stem cell therapy. Many investors and large companies that have preferred to avoid the possible controversies of embryonic stem cells are finding alternatives in adult stem cells. The potential use of adult stem cells for therapies may offer substantial opportunities for cell therapy companies looking to capitalize on a market that is currently estimated to exceed $500 million in the U.S. and Europe
Copyright ® Genética Aplicada. Todos os direitos reservados.